Abstract:Jianhua Wu, 1, 2 Yisha Wu, 1 Peng Jin, 3 Xiaoxue Zi, 3 Yuzhu Wan, 1 Kaiyue Sun, 1, 4 Li Shi, 1, 3 Deyun Wang 5 1 Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China; 2 Department of Otolaryngology Head and Neck Surgery, Binzhou People's Hospital, Binzhou, Shandong, People's Republic of China; 3 Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China; 4 Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China; 5 Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Correspondence: Li Shi, Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, Shandong, 250033, People's Republic of China, Tel +86 0531 83086278, Fax +86 0531 83086279, Email Kaiyue Sun, Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250022, People's Republic of China, Tel +86 0531 83086277, Fax +86 0531 83086279, Email Background: Circular RNAs (circRNAs) are a novel class of endogenous non-coding RNA molecules in eukaryotes, involved in many essential biological processes. However, their role in allergic rhinitis (AR) has not been extensively studied. Methods: The expression levels of hsa_circRNA_100791 were measured using qRT-PCR in peripheral blood mononuclear cells (PBMCs) and nasal mucosa from AR patients. The biological function of hsa_circRNA_100791 in AR was investigated through RNA-seq and a series of in vitro experiments. Western blotting, luciferase reporter assays, and rescue experiments were conducted to elucidate the molecular mechanisms underlying hsa_circRNA_100791. Additionally, a mouse model was used to assess the functional role of hsa_circRNA_100791 in vivo. Results: Upregulation of hsa_circRNA_100791 was observed in both PBMCs and nasal mucosa of AR patients. In vitro, increased expression of hsa_circRNA_100791 promoted the production of pro-inflammatory mediators (IL-1β, IL-4, IL-5, IL-6, IL-8, IL-13, IL-17, IL-18, IL-33, TNF-α, and NF-κB) and inhibited IL-2 and IFN-γ. Conversely, knockdown of hsa_circRNA_100791 both in vitro and in vivo alleviated AR symptoms, reduced pro-inflammatory mediators, and enhanced IL-2 and IFN-γ levels. Mechanistically, we found hsa_circRNA_100791 contributing to the pathological processes of AR, which upregulate TRIM13 via sponging miR-487b-5p. Conclusion: Our study demonstrated that hsa_circRNA_100791 mitigates the inhibitory effect of miR-487b-5p on Trim13 by directly binding to miR-487b-5p. This interaction regulates the expression of inflammatory factors and facilitates AR. Thus, hsa_circRNA_100791 could be a promising new therapeutic target for AR. Keywords: allergic rhinitis, hsa_circ_100791, miR-487b-5p, Trim13, diagnosis, inflammation, NF-κB AR is one of the most common chronic airway diseases, characterized by IgE-mediated type 2 inflammation in response to inhaled allergens. Clinically, AR presents with nasal congestion, itching, sneezing, and rhinorrhea. 1,2 During acute allergic reactions, inflammatory mediators primarily released by mast cells (eg histamine and leukotrienes) are responsible for the development of AR symptoms. Additionally, activated allergen-specific TH2 cells secrete large amounts of IL-4, IL-5, and IL-13, which contribute to the enhancement and persistence of type 2 mucosal inflammation in AR. 1–3 However, the specific molecular and cellular mechanisms underlying these processes are not yet fully understood. MicroRNAs (miRNAs) are small non-coding RNA molecules that can decrease gene expression either by degrading mRNA or by binding to the 3ʹ-untranslated region of target mRNAs to inhibit translation. 4 Several studies have suggested that miRNAs play a role in the pathological processes of AR. 5–7 For instance, miR-133b has been reported to alleviate allergic symptoms in a mouse model of AR. 7 Additionally, miR-487b has been shown to mitigate AR in an OVA-induced animal model by inhibiting the IL-33/ST2 signaling pathway, and reduced expression of miR-487b can lead to increased production of pro-inflammatory cytokines such as IL-6 and TNF-α. 5 Furthermore, miR-487b is known to play a significant role in allergic airway inflammation. 8 Despite these insights, the precise molecular mechanisms underlying -Abstract Truncated-

CircMIRLET7BHG, upregulated in an m6A-dependent manner, induces the nasal epithelial barrier dysfunction in allergic rhinitis pathogenesis

CircRNA Expression Profiles and Circrna-Mirna-mrna Crosstalk in Allergic Rhinitis

Altered Circular RNA Expression Profiles in an Ovalbumin-Induced Murine Model of Allergic Rhinitis.

circARRDC3 contributes to interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells via the miR-375/KLF4 axis

m6A mRNA methylation-mediated MAPK signaling modulates the nasal mucosa inflammatory response in allergic rhinitis

Hsa_circRNA_100791 Modulates Trim13 Through Sponging miR-487b-5p to Facilitate Inflammation in Allergic Rhinitis

MIR222HG attenuates macrophage M2 polarization and allergic inflammation in allergic rhinitis by targeting the miR146a-5p/TRAF6/NF-κB axis

Altered Microrna Expression Profiles of Extracellular Vesicles in Nasal Mucus from Patients with Allergic Rhinitis

A Potential circRNA-miRNA-mRNA Regulatory Network in Asthmatic Airway Epithelial Cells Identified by Integrated Analysis of Microarray Datasets

Knockdown of lncRNA ANRIL suppresses the production of inflammatory cytokines and mucin 5AC in nasal epithelial cells via the miR-15a-5p/JAK2 axis

CircZNF652 Promotes the Goblet Cell Metaplasia by Targeting the Mir-452-5p/jak2 Signaling Pathway in Allergic Airway Epithelia.

Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models

ADRB2 Suppresses IL-13-induced Allergic Rhinitis Inflammatory Cytokine Regulated by Mir-15A-5p

Influences of miR-378a-3p on the Pathogenesis of Allergic Rhinitis via GzmB-Mediated Inflammatory Reaction

MicroRNA-29 Mediates Anti-Inflammatory Effects and Alleviation of Allergic Responses and Symptoms in Mice with Allergic Rhinitis

MiR-150-5p regulates the functions of type 2 innate lymphoid cells via the ICAM-1/p38 MAPK axis in allergic rhinitis

Bioinformatics-Based Approaches Predict That MIR-17-5P Functions in the Pathogenesis of Seasonal Allergic Rhinitis Through Regulating ABCA1 and CD69

MiR-193b-3p Regulates TLR4 Expression to Inhibit Inflammation by Targeting ETS1 in Allergic Rhinitis.

MicroRNA-214-3p facilitates M2 macrophage polarization by targeting GSK3B

Mir-143 Inhibits Interleukin-13-induced Inflammatory Cytokine and Mucus Production in Nasal Epithelial Cells from Allergic Rhinitis Patients by Targeting IL13Rα1

The Circular RNA Circtxnrd1 Promoted Ambient Particulate Matter-Induced Inflammation in Human Bronchial Epithelial Cells by Regulating Mir-892A/cox-2 Axis.